Anti-breast cancer potential of thieno-pyrimidine derivatives as VEGFR-2 inhibitors. [PDF]
Alsfouk AA +10 more
europepmc +1 more source
In silico discovery of alkaloids as VEGFR-2 inhibitors with favorable toxicity profiles: insights from molecular dynamics and MM/GBSA. [PDF]
da Silva Maués N +3 more
europepmc +1 more source
Discovery of thieno[2,3-<i>d</i>]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and <i>in vivo</i> validation in a breast cancer model. [PDF]
El-Shafey HW +8 more
europepmc +1 more source
Comparison between conventional, grinding, and microwave synthesis of methylpyrazoles as VEGFR-2/HSP90 dual inhibitors. [PDF]
Husseiny EM +4 more
europepmc +1 more source
Synthesis of thiazoloquinolinone derivatives: molecular docking, MD simulation, and pharmacological evaluation as VEGFR-2 inhibitors. [PDF]
Amiri Z, Bayat M, Gheidari D.
europepmc +1 more source
From Deep Learning to the Discovery of Promising VEGFR-2 Inhibitors. [PDF]
Yucel MA +6 more
europepmc +1 more source
Retraction: MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells. [PDF]
europepmc +1 more source
Yijing Decoction improves premature ovarian failure in rats by activating VEGF/VEGFR-2/FAK pathway. [PDF]
Gao R, Wu Y, Tang Y, Wu K, Guo B.
europepmc +1 more source
Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
Vascular endothelial growth factor (VEGF-A) plays an essential role in tumor-associated angiogenesis, exerting its biological activity by binding and activating membrane receptors, as vascular endothelial growth factor receptor 1 and 2 (VEGFR-1, VEGFR-2).
Fernando Ferreira +2 more
exaly +2 more sources
Related searches:
Recent Development of Multi-Target VEGFR-2 Inhibitors for the Cancer Therapy
Bioorganic Chemistry, 2023Shuo Yuan, Li-Rong Zhang, Saiyang Zhang
exaly

